packageZilucoplan

zilucoplan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Zilucoplan is a complement inhibitor used to treat myasthenia gravis. It is an approved medicine, authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q107340140 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:zilucoplan
ATC codes:L04AJ06
DrugBank:DB15636
PubChem CID:133083018
Wikidata:Q107340140
formula:C172H278N24O55
molar mass:3562.23 g/mol (PubChem CID 133083018)
logP:4.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown